The induction of plasmacytomas (PCTs) in the peritoneal cavity of BALB/cAn mice by plastics, paraffin oils or silicone gels is a model system for identifying the steps and stages of neoplastic development. An early oncogenic event in plasmacytomagenesis (PCTGEN) is a chromosomal translocation that illegitimately recombines c-myc with an Ig locus gene resulting in deregulation of c-myc transcription. Recent evidence from a highly sensitive nested PCR detection method indicates this step probably takes place before the introduction of the peritoneal inducing agent. A second consistent tumor suppressor phenotype, i.e., loss of the functional TGF-b receptor TbRII has been identified. Many of the steps in PCTGEN take place in the chronic inflammatory microenvironment of the oil granuloma induced by pristane or silicone gels. PCTGEN can be dramatically inhibited by the chronic administration of the cyclooxygenase inhibitor, indomethacin. This suggests that a prostaglandin produced by an accessory cell is an important effector in plasmacytoma develoment. In vitro studies implicate PGE2 and a cAMP sensitive step as important factors in stimulating IL-6 production. Recent work demonstrating the resistance of BALB/c.CBA/N congenic mice to PCT induction implicates the btk pathway and the ability of B cells in BALB/c mice to respond to auto and environmental (gut flora) antigens in PCTGEN. Much of our current effort focuses on the role of environmental factors in PCTGEN. The presence of the conventional microflora appears to be critical. We characterize the antigen binding activities of myeloma proteins for clues that link the gut flora to B cell clonal longevity. We are studying the role of other environmental factors relating to diet, i.e., fatty acid content, on PCTGEN.

Agency
National Institute of Health (NIH)
Institute
Division of Basic Sciences - NCI (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC005596-31
Application #
6433040
Study Section
(LG)
Project Start
Project End
Budget Start
Budget End
Support Year
31
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Casellas, Rafael; Yamane, Arito; Kovalchuk, Alexander L et al. (2009) Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes. Immunology 126:316-28
Potter, Michael (2007) The early history of plasma cell tumors in mice, 1954-1976. Adv Cancer Res 98:17-51
Park, Eun Sung; Shaughnessy Jr, John D; Gupta, Shalu et al. (2007) Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasia. BMC Genomics 8:302
Kim, Byung-Gyu; Li, Cuiling; Qiao, Wenhui et al. (2006) Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 441:1015-9
Potter, Michael (2003) Neoplastic development in plasma cells. Immunol Rev 194:177-95
Janz, Siegfried; Potter, Michael; Rabkin, Charles S (2003) Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals. Genes Chromosomes Cancer 36:211-23
Potter, M; Jones, G; Dubois, W et al. (2000) Myeloma proteins that bind Hsp65 (GroEL) are polyreactive and are found in high incidence in pristine induced plasmacytomas. Curr Top Microbiol Immunol 252:265-71
Potter, M; Melchers, F (2000) Opinions on the nature of B-1 cells and their relationship to B cell neoplasia. Curr Top Microbiol Immunol 252:307-24
Potter, M (1999) Indomethacin inhibition of pristane plasmacytomagenesis in genetically susceptible inbred mice. Adv Exp Med Biol 469:151-6
Potter, M; Wax, J S; Hansen, C T et al. (1999) BALB/c.CBA/N mice carrying the defective Btk(xid) gene are resistant to pristane-induced plasmacytomagenesis. Int Immunol 11:1059-64

Showing the most recent 10 out of 11 publications